Thermo Scientific™ Tango™ CCR6-blaU2OS DA Assay Kit
Manufacturer: Thermo Scientific™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | K1765-Each-of-1 | In Stock | ₹ 97,709.52 |
K1765 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 97,709.52
GST (18%): ₹ 17,587.714
Total Price: ₹ 1,15,297.234
Accession Number
NM_004367.3
Cell State
Division-Arrested Cells
Cytoplasmic Tail
Native Tail
Gene Symbol
CCR6
Product Line
Tango™
Reporter Gene
BLA (Beta-Lactamase)
Cell Line
U2OS
Druggable Target
GPCR
Assay Entry
Cell-based beta-arrestin recruitment
Content And Storage
Each kit contains sufficient quantities of division arrested (DA) cells and substrate to assay 1 x 384 well plate. (Other materials are required separately; please refer to the protocol).Includes:• Tango™ CCR6-bla U2OS DA cells• LiveBLAzer™-FRET B/G Loading Kit, 70 μg• Solution D• Tango™ CCR6-bla U2OS DA Assay Protocol• LiveBLAzer™-FRET B/G Loading Protocol• Certificate of AnalysisThe Tango™ CCR6-bla U2OS DA cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt.
Detection Method
Fluorescence
Population Status
Single Cell Clone Origin
Quantity
8 x 106Cells
Target Entry
CCR6
System Type
Tango™
Related Products
Description
- The Tango™ CCR6-bla U2OS cells contain the human Chemokine (C-C motif) Receptor 6 (CCR6) linked to a TEV protease site and a Gal4-VP16 transcription factor stably integrated into the Tango™ GPCR-bla U2OS parental cell line
- This parental cell line stably expresses a beta-arrestin/TEV protease fusion protein and the beta-lactamase (bla) reporter gene under the control of a UAS response element
- The Tango™ CCR6-bla U2OS cells cells have been functionally validated for Z' factor and EC50 concentrations of established ligands
- In addition, Tango™ CCR6-bla U2OS cells have been tested for assay performance under variable conditions
- These data are found in the Validation & Assay Performance Summary for each product
- Division Arrested cells are irreversibly division arrested using a low-dose treatment of Mitomycin C, and have no apparent toxicity or change in cellular signal transduction.